Back to search

Article

<i>In vivo</i> correction of cystic fibrosis mediated by PNA nanoparticles

2022-01-28

Abstract excerpt

Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. We sought to correct the multiple organ dysfunction of the F508del CF-causing mutation using systemic delivery of peptide nucleic acid gene editing technology mediated by biocompatible polymeric nanoparticles. We confirmed phenotypic and genotypic modification in vitro in primary nasal epithelial ce...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f4911996-dd34-50dd-bf6d-a63c2635463e
DOI
10.1101/2022.01.28.478191
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
<i>In vivo</i> correction of cystic fibrosis mediated by PNA nanoparticlesDOI 10.1101/2022.01.28.478191
Select a neighboring publication to make it the new centre.